Patents by Inventor Alejandro Vaquero

Alejandro Vaquero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9942330
    Abstract: Session Manager anti-looping creates a model that is an effective barrier to looping, efficiently identifying a loop condition by maintaining temporary individual call counters for header sets within temporal parameters and terminating the loop condition upon detection. The system provides an administrator with adjustable parameters for loop detection count and loop detection interval, thereby allowing protection against loop conditions, both inadvertent and intentional.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: April 10, 2018
    Assignee: Extreme Networks, Inc.
    Inventors: Harsh V. Mendiratta, Stephen Andrew Baker, Alejandro Vaquero, Stephen R. Durney, Ryan Scott Wallach, William G. Bahr
  • Publication number: 20140317190
    Abstract: Session Manager anti-looping creates a model that is an effective barrier to looping, efficiently identifying a loop condition by maintaining temporary individual call counters for header sets within temporal parameters and terminating the loop condition upon detection. The system provides an administrator with adjustable parameters for loop detection count and loop detection interval, thereby allowing protection against loop conditions, both inadvertent and intentional.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 23, 2014
    Applicant: Avaya Inc.
    Inventors: Harsh V. Mendiratta, Stephen Andrew Baker, Alejandro Vaquero, Stephen R. Durney, Ryan Scott Wallach, William G. Bahr
  • Publication number: 20070065890
    Abstract: The present invention is a method for promoting facultative heterochromatin formation using SirT1. Using novel anti-SirT1 and anti-acetylated histone H1 antibodies, human SirT1 protein was shown to interact with and deacetylate histone H1 at lysine 26. Moreover, SirT1 was shown to mediate deactylation of histones H3 and H4 and spreading of hypomethylated H3-K79 with resultant silencing. Using the anti-SirT1 antibody, methods of diagnosing cancer are also provided.
    Type: Application
    Filed: August 18, 2006
    Publication date: March 22, 2007
    Inventors: Danny Reinberg, Alejandro Vaquero